SCHEMBL2356964

SCHEMBL2356964

COC(C)Oc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.50
KDM4E B2RXH2 1/20 0.47
CHRNB4 P30926 2/20 0.44
CHRNA3 P32297 2/20 0.44
LTA4H P09960 2/20 0.42
LMNA P02545 2/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
TSHR P16473 3/20 0.41
GAA P10253 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
CYP2C19 P33261 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
NISCH Q9Y2I1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11696624 0.91 LTA4H (0.58) CA4KDM4ELTA4HTSHRMAOA
SCHEMBL542873 0.89 KDM4E (0.50) CA4KDM4ECHRNB4CHRNA3LTA4H
SCHEMBL29159322 0.84 KDM4E (0.47) CA4KDM4ECHRNB4CHRNA3LTA4H
SCHEMBL9296320 0.84 KDM4E (0.47) CA4KDM4ECHRNB4CHRNA3LTA4H
Methylamine SCHEMBL10763289 0.84 KDM4E (0.47) CA4KDM4ECHRNB4CHRNA3LTA4H
SCHEMBL10749798 0.83 CA4 (0.64) CA4KDM4ELTA4HTSHRALDH1A1
Dimethylamine SCHEMBL9504815 0.82 KDM4E (0.46) CA4KDM4ECHRNB4CHRNA3LTA4H
SCHEMBL9770385 0.82 KDM4E (0.46) CA4KDM4ECHRNB4CHRNA3LTA4H
SCHEMBL10724500 0.81 CHRNB4 (0.44) KDM4ECHRNB4CHRNA3MTNR1AMTNR1B
SCHEMBL13717070 0.81 KDM4E (0.36) CA4KDM4ECHRNB4CHRNA3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115215733-A Preparation method of 2-bromo-3-fluorophenol 西安拓超生物科技有限公司 2022-10-21 CN claimed
EP-2662365-A1 IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE Idemitsu Kosan Co., Ltd. (JP) 2013-11-13 EP claimed
US-20130270541-A1 IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2013-10-17 US claimed
US-6660460-B2 For removing material selected from photoresist, probing ink or wafer bonding adhesive from a substrate SHIPLEY COMPANY, L.L.C. 2003-12-09 US claimed
US-20030030030-A1 Stripper SHIPLEY COMPANY, L.L.C. (US) 2003-02-13 US claimed
US-6475292-B1 Photoresist stripping method SHIPLEY COMPANY, L.L.C. 2002-11-05 US claimed
EP-1178358-A2 Stripper Shipley Company LLC (US) 2002-02-06 EP claimed
US-20240109842-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-04-04 US disclosed
WO-2023167019-A1 PHOSPHORUS-CONTAINING (METH)ACRYLOYL COMPOUND, METHOD FOR PRODUCING SAME, AND FLAME-RETARDANT COMPOSITION AND LAMINATED BOARD FOR ELECTRONIC CIRCUIT BOARD CONTAINING SAME 日鉄ケミカル&マテリアル株式会社 2023-09-07 WO disclosed
US-20230152699-A1 FILM-FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2023-05-18 US disclosed
US-20230152699-A1 FILM-FORMING COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2023-05-18 US disclosed
EP-3246317-B1 BTK INHIBITOR HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC (CN) 2023-02-22 EP disclosed
CN-115215733-A Preparation method of 2-bromo-3-fluorophenol 西安拓超生物科技有限公司 2022-10-21 CN disclosed
WO-2006136309-A1 CRIPOWELLINS AND SYNTHETIC DERIVATIVES THEREOF USED AS MEDICAMENTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-12-28 WO disclosed
US-6660460-B2 For removing material selected from photoresist, probing ink or wafer bonding adhesive from a substrate SHIPLEY COMPANY, L.L.C. 2003-12-09 US disclosed
US-20030030030-A1 Stripper SHIPLEY COMPANY, L.L.C. (US) 2003-02-13 US disclosed
US-6475292-B1 Photoresist stripping method SHIPLEY COMPANY, L.L.C. 2002-11-05 US disclosed
EP-1178358-A2 Stripper Shipley Company LLC (US) 2002-02-06 EP disclosed
WO-2000042043-A1 PYRROLO[2,3-d]PYRIMIDINES AS ANTIVIRAL AGENTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2000-07-20 WO disclosed
US-4404354-A FROM P-DIALKOXYBENZENES, HEAT RESISTANT DAINIPPON INK AND CHEMICALS, INC. (JP) 1983-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130270541-A1 IMIDAZOLE COMPOUND PRODUCTION METHOD, IMIDAZOLE COMPOUND, IMIDAZOLE-BASED COMPOUND, ORGANIC METAL COMPLEX, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE NFXL1, NFE2L2, ZC3HAV1L CA4 1964/4885KDM4E 825/4885CHRNB4 3684/4885
US-20240109842-A1 ACRYLAMIDE COMPOUNDS HPGDS, MYADM, ACR CA4 4870/4885KDM4E 4294/4885CHRNB4 4015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.